Related Experiment Video
Updated: May 13, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
The longitudinal study of morphometric measurement changes in progressive supranuclear palsy
Abstract:
Midbrain atrophy is strongly associated with progressive supranuclear palsy (PSP) disease severity. Preclinical evidence suggests that midbrain-based Magnetic Resonance Parkinsonism Index (MRPI) measurements are reliable and sensitive morphometric biomarkers for PSP diagnosis. The study explored the longitudinal changes of MRPI measurements in PSP patients. Midbrain-based morphometric measurements and the corresponding annual percentage changes were measured and further used to evaluate the associations with disease progression. Compared with healthy controls, baseline quantitative analyses in patients with PSP revealed significant differences in all morphometric measurements expect pons. Baseline comprehensive measurements were significantly associated with baseline PSP rating scale score (P < 0.05). Our study demonstrates that midbrain-based MRPI measurements holds promise for monitoring PSP disease progression.
Insights
Midbrain atrophy correlates with progressive supranuclear palsy (PSP) severity. Midbrain-based Magnetic Resonance Parkinsonism Index (MRPI) measurements show potential for tracking PSP progression and aiding diagnosis.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
Background:
- Midbrain atrophy is a key indicator of progressive supranuclear palsy (PSP) disease severity.
- Midbrain-based Magnetic Resonance Parkinsonism Index (MRPI) measurements show promise as diagnostic biomarkers for PSP.
Purpose of the Study:
- To investigate longitudinal changes in MRPI measurements in PSP patients.
- To assess the association between MRPI measurements and PSP disease progression.
Main Methods:
- Quantitative morphometric measurements of the midbrain were performed.
- Annual percentage changes in MRPI measurements were calculated.
- Associations between baseline measurements and PSP rating scale scores were evaluated.
Main Results:
- Patients with PSP exhibited significant differences in baseline midbrain morphometric measurements compared to healthy controls (excluding the pons).
- Baseline MRPI measurements were significantly correlated with baseline PSP rating scale scores.
- Longitudinal MRPI measurements were analyzed for disease progression.
Conclusions:
- Midbrain-based MRPI measurements are sensitive to changes in PSP.
- MRPI measurements demonstrate potential as reliable biomarkers for monitoring PSP disease progression.
More Related Videos
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Longitudinal Research
Longitudinal Studies